SABER II Success Story: SIM COVID

Vysnova supports NAMRU-2 in conducting this research study including the development of the protocol and related SOPs, getting HPRO approval, performing sample collection at sites, storing and transferring samples to different labs, managing data, and completing data analysis.

Project Spotlight: MRS SEA

  Project Purpose NAMRU-2 has funded Vysnova Partners to execute research re-stratifying the epidemiology of Malaria in Vietnam. The project will also identify more effective control and elimination interventions, and enhance malaria…

Vysnova Team Member Spotlight: Stephane Daphnis

Vysnova's Team Member Spotlight is on Stephane Daphnis! Stephane is a REDCap and EHR Program Coordinator.

Press Release: Vysnova Receives Award Under GSA OASIS UNR, POOL 4 Multiple Awards

Vysnova Partners, Inc. (Vysnova) is pleased to announce that we have received an award under the GSA OASIS Unrestricted (OASIS UNR), Pool 4 Multiple Award (MA), Indefinite Delivery, Indefinite Quantity (ID/IQ) contract as a Prime Contract Awardee. Pool 4 is focused on research and development. The OASIS contract has a $60 Billion ceiling.

Project Spotlight: Vysnova Supports NAMRU 2 Research

The purpose of the program is to support NAMRU-2 (Navy Medical Unit 2 (NAMRU 2) Southeast Asia Biosurveillance and Epidemiology Research (SABER) II is to improve disease surveillance activities, evaluate novel diagnostics products and therapeutic interventions, test disease control strategies, and develop local expertise via training to detect and respond to emergent disease threats. Working together, under SABER II, we can understand and combat infectious diseases and vector-borne illnesses including Malaria, Dengue, Chikungunya as well as the burden and distribution of Swine Flu, Bird Flu, SARS-CoV-2, MERS-CoV, and other emerging infectious diseases.

Vysnova Team Member Spotlight: Isabella Malcolm

Vysnova's team member spotlight is on Isabella Malcolm. Isabella is an Operations Associate for Vysnova Partners.